AstraZeneca's IL-33-targeting antibody tozorakimab has made the grade in two phase 3 chronic obstructive pulmonary disease (COPD) trials, raising the prospects of a class that has recorded some ...
AstraZeneca’s chronic obstructive pulmonary disease (COPD) candidate has hit the mark in a pair of phase 3 trials, delivering broad efficacy with a mechanism that yielded mixed data for Roche and ...
Clinical benefits of the interleukin-33 inhibitor were observed in a broad population, including both former and current smokers, regardless of eosinophil levels. Topline results were announced from ...
On April 1, the National Council Licensure Examination for registered nurses will include more competencies in care management and basic care and comfort, while most of the exam structure, scoring and ...
The therapeutic variations among patients with chronic obstructive pulmonary disease (COPD) present ongoing treatment challenges. However, the two currently approved biologics, dupilumab and ...
WAYNETOWN, Ind. — Tony Manion doesn't miss a workout. Seriously. Three hours a day, every day. "You just make a choice to do it," Manion said, between reps from his home gym in rural Montgomery County ...
In support of World COPD Day on November 19, the Global Initiative for Chronic Obstructive Lung Disease (GOLD), is drawing attention to the importance of correctly diagnosing COPD earlier - with the ...
Chronic obstructive pulmonary disease, or COPD, is often thought of as a condition that only affects longtime smokers. In reality, the disease reaches far beyond that group. Women are ...
The National Council Licensure Examination, or NCLEX, averaged an 87.8% passage rate in 2023, according to the National Council of State Boards of Nursing. The council surveyed more than 2,000 nursing ...
COPD Infection Management and Mitigation Strategies: Focusing on Diagnostics and Targeted Treatments
As the “Swiss Army knife of bacteria,” methicillin-resistant Staphylococcus aureus is quite the problematic organism, said John Osiecki, PhD. Among the diverse group of gram-positive bacteria ...
Chronic obstructive pulmonary disease, or COPD, is the fourth leading cause of death worldwide, responsible for 3.5 million deaths in 2021, according to the World Health Organization. It’s a common ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results